BOSTON & GENEVA--(BUSINESS WIRE)--PHT Corporation, a leading provider of technologies used to collect patient-driven eData for clinical research, announced today that its LogPad® System has been selected by Agile Therapeutics for use in its SECURE Phase 3 trial for its investigational product candidate, Twirla®.
The LogPad System is the world’s most widely-used electronic patient reported outcome (ePRO) eDiary for patient-focused eClinical research that speeds the delivery of new drugs and therapies. Sponsors, clinicians and patients rely on the LogPad System for ease of use, simplicity, PHT’s regulatory compliance, and data integrity.
Help employers find you! Check out all the jobs and post your resume.
